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Abstract 
Pathologica'lly, Alzheimer's disease (AD) is characterized 
by deposits of neuritic plaques (NP) and neurofibrillary 
tangles (NFT) typically found in the cerebral cortex, 
hippocampus, and basal forebrain. Increasing evidence 
suggests that the major constituent of NP, a B-amyloid protein 
(BAP) composed of 39-42 amino acids, possesses neurotoxic 
properties. It has been reputed that the neurotoxic 
properties of BAP(1-40) may be dependent on the aggregational 
state of the peptide. Recent studies have demonstrated in 
vitro that a fragment of the B-amyloid protein, BAP(25-35), 
disrupts intracellular calcium homeostasis, decreases neuronal 
survival, and potentiates the toxicity of excitatory amino 
acids (EAA). While some evidence supports the direct in vivo 
toxicity of BAP, the extent of neuronal damage has not been 
compared with standard lesions made by EAAs. Moreover, 
currently the effects of intracerebral injections of BAP(25­
35) on learning and memory in the rat is unknown. Therefore, 
in this study a comparative behavioral and histological 
assessment was conducted following bilateral intrahippocampal 
injections of BAP(25-35), ibotenic acid (IBO), BAP(25-35)+IBO, 
and incubated BAP(25-35) (1 week at 37 C). A radial arm maze 
and Morris water maze were utilized for comparative learning 
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and memory assessment. Preliminary results indicate that 
there is a clear 'disruption of learning performance in animals 
co-injected with low doses of BAP(25-35) (4nmol/ul) + IBO 
(lug/ul) while identical doses inj ected separately had no 
effect. The deficits in learning observed following 
injections of BAP(25-35)+IBO and the high does of IBO was not, 
however, due to disruptions in motor behavior as there was no 
difference found between groups on a treadmill test in those 
that ran the maze and those that did not. In support of the 
behavioral results, preliminary histological analyses revealed 
cytotoxic effects in the hippocampus following injections of 
BAP(25-35) '+ IBO or a high does of IBO. This study suggests 
that the injection of BAP (25-35) into the hippocampus promotes 
the vulnerability of neurons to excitotoxic damage in vivo and 
disrupts learning/memory in rats. 
• 
An Animal Model of AD 5 
The number' of people afflicted by neurodegenerative 
disorders has been increasing. Of particular interest is 
Alzheimer's disease (AD) , which is characterized by 
progressive decay in cognitive abilities (e.g. memory, 
reasoning capability) associated with neuronal degeneration 
and synapse loss. Alzheimer's disease is the 4th leading 
cause of adult death in the u.s. after heart disease, cancer, 
and stroke, claiming more than 100,000 live per year. If no 
cure is found, the number of individuals affected by AD will 
double by the year 2000 and quintuple by the year 2040 [7]. 
Currently, neither the etiology nor the pathogenesis of AD is 
clearly understood. Therefore, it is evident that Alzheimer's 
disease will become the epidemic of the future if no effective 
treatment is found. 
Neurohistological and neuroanatomical analyses have 
revealed that the pathological hallmark of AD is the 
accumulation of neuritic plaques (NP) and neurofibrillary 
tangles (NFT) , typically found in the cerebral cortex, 
hippocampus, and basal forebrain [19]. These lesions have 
been found to accompany substantial synapse loss and neuronal 
degeneration [20]. However, whether neurodegeneration is 
caused by plaque accumulation or plaque formation is somehow 
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a result of cell death is somewhat controversial. 
Neuritic plaques are composed of a core component, the B­
amyloid protein (BAP) which consists of 39-42 amino acids [9] 
and is enzymatically cleaved from a larger amyloid precursor 
protein (APP) by an unknown pathogenic mechanism and is 
deposited in the extracellular matrix, progressively 
developing from a diffuse, soluble state to a neuritic, 
insoluble form [13]. In contrast, neurofibrillary tangles are 
filamentous intracellular deposits that are found in cell 
bodies and neurites of neurons that are marked for eventual 
degeneration [6]. NFT are relatively insoluble and remain 
when the death of the tangle-bearing neuron is complete, so 
called "ghost tangles". Paired helical filaments (PHF) are 
the major structural components of NFT and tau, a microtubule 
associated protein, is an integral constituent of PHFs [3]. 
Presumably, recent evidence suggests that a 
hyperphosphorylation event occurs to the tau protein in 
degenerating neurons [12]; therefore, antibodies which 
recognize the phosphorylated tau (e.g. Alz-50) have been 
widely utilized to immunostain tangle-bearing neurons and 
normal nerve cells that are at risk of developing 
neurofibrillary pathology [6]. 
Substantial data suggest that the accumulation of BAP 
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occurs prior to tangle formation; therefore, mature BAP may be 
the cause of NFT induction, and thus neuronal degeneration 
[14]. Whether this event is the pathogenic mechanism of cell 
death in AD is uncertain. Nevertheless, increasing evidence 
suggests that B-amyloid protein possesses neurotoxic 
properties. In 1991, Yankner and Kowall reported that BAP (1­
40), when injected into the hippocampus of rats, causes 
neurodegeneration and a marked induction of Alz-50 
immunoreactivity [11]. While several laboratories were able 
to observe the in vivo neurotoxicity of BAP along with 
corresponding antigenic changes, however, others were unable 
to replicate Yanker's initial findings. For instance, 
Podlisny et ale injected synthetic BAP (1-40) in monkey 
cerebral cortex but found no cellular changes resembling AD 
pathology [17]. 
One possible explanation for these conflicting reports 
may be related to the self-aggregational properties of BAP(l­
40) which nos not controlled for in earlier studies. pike et 
ale reported that when freshly solubilized (new) BAP(1-42) is 
applied, there is no difference in neuronal survival of 
hippocampal cultures when compared to saline controls while 
identical doses of incubated BAP(1-42) (7 days at 37 C), 
however, dramatically reduced neuronal survival [15]. A later 
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study by pike and colleagues confirmed their previous results 
and showed that the incubation of BAP(1-42) under 
physiological conditions adopts an aggregated, insoluble form 
and exerts neurotoxicity in cultured neurons. Following 
incubation, B-pleated sheet-like aggregates were observed 
under a light microscope [16]. 
until very recently, the molecular mechanisms of BAP(25­
35)-induced neurotoxicity has not been investigated. Yankner 
et al. recently reported that BAP(1-40) is neurotoxic to 
differentiated hippocampal cultures, and that the neurotoxic 
activity resides within the amino acids 25-35 of the full 
peptide [21]. Furthermore, Joseph and Han reported that this 
putative neurotoxic fragment, BAP(25-35) , causes a specific 
and dose-dependent increase in intracellular calcium by an 
influx of extracellular calcium in PC12 cultured neurons [8]. 
Arispe and colleagues later showed that BAP(1-40) increases 
intracellular calcium by spanning the bilipid membrane and 
forming calcium channel-like ionophores. It has been 
suggested that the formation of calcium channels is possible 
only when the BAP polymerizes into stable aggregates (dimer, 
trimers, tetramers, etc.) due to the relative short length of 
the peptide [1]. In addition, Hu and EI-Fakahany showed that 
BAP (25-35) stimulates the formation of cGMP via a calcium 
----.
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dependent increase in nitric oxide synthase (NOS) in cultured 
PC12 neurons [unpublished manuscript]. Several years earlier, 
Koh et al. (1990) had reported that BAP potentiated the 
toxicity of excitatory amino acids (e.g. ibotenic & kainic 
acid) in cultured cortical neurons [10]. Collectively, these 
results suggest that a mechanism of action related to the 
pathology of Alzheimer's disease may be via a synergistic 
action of BAP with an excitatory amino acid (e.g. glutamate), 
which leads to a disruption of cellular calcium homeostasis. 
This process may be further exacerbated by the aggregational 
properties of BAP. 
One of the structures that has been found to be 
selectively targeted for degeneration in brains of AD patients 
is the hippocampus [19]. In an effort to establish an animal 
model of Alzheimer's disease, the present study compared the 
effects of excitotoxic lesions of the hippocampus with 
intrahippocampal injections of different doses of BAP(25-35) 
on learning/memory in the rat. Previous studies have shown 
that excitotoxic lesions using different glutamate analogs 
produce dramatic effects on learning when injected into the 
hippocampus. In order to examine the specificity of the 
lesions, histological as well as immunocytochemical procedures 
were employed. The behavioral paradigms used in the present 
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study were the a-arm radial arm maze, Morris Water Maze, and 
a treadmill test'for motor activity. It was hypothesized that 
there would be a dose and aggregation dependent neurotoxic 
action of BAP(2S-3S), and that BAP(2S-3S) will potentiate the 
toxicity of ibotenic acid. The learning and memory 
performance of the groups should thus mirror the extent of 
lesions made by the injections. 
Method 
Animals and Surgery 
In a total of 39 Long-Evans rat, stereotaxic surgery was 
performed. Three of these rats died as a result of the surgery 
(BAP(high), BAP(low), and BAP(high-incubated», 2 died during 
RAM testing ( 2 salines) and 1 died immediately upon the 
completion of the RAM testing (BAP(low». They were 
individually housed and maintained in a controlled light/dark 
cycle environment (lights on 6:00 and off at 21:00). B­
amyloid(2S-35) was purchased from Bachem Inc. (Torrence, CA) 
and ibotenic acid from sigma Chemicals (st. Louis, MO). Eight 
to 10 days prior to testing, rats were anesthetized with 
sodium pentobarbital (SOmg/kg) and placed in a sterotaxic 
surgery apparatus in the flat-skull position. A burr hole was 
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made through the skull and a 2-ul Hamilton syringe was lower 
down to the desired coordinates (AP=-3.6, ML=±2.3, DV=-3.6) 
over a period of 3 minutes. BAP(25-35) and ibotenic acid (IBO) 
were dissolved in luI of vehicle (phosphate buffered saline) , 
and all groups received bilateral injections into the 
hippocampus over a period of 4 minutes • The groups were group 
1) BAP(25-35) low (n=3), 4 nmoli group 2) BAP(25-35) high 
(n=4) , 8nmoli group 3) IBO low (n=4) , 1ugi group 4) IBO high 
(n=4) , 2.8ugi group 5) BAP(25-35) low + IBO low (n=6)i group 
6) BAP(25-35) high (n=5) , incubated at 37 C for 7 daysi group 
7) phosphate buffered saline. In order to prevent back flow 
and minimize tissue damage, the syringe was left in place for 
5 minutes and removed over a duration of 3 minutes. Following 
surgery, animals were given 10-12 days for recovery. 
Radial Arm Maze 
Beginning the first day of habituation, rats were 
regularly handled to minimize stress and maintained at 80-90% 
of their ad libitum weight for the duration of radial arm maze 
and locomotor testing. The 8-arm radial arm maze (RAM) was 
made of plywood painted black and stood 30 inches high with a 
total diameter of 72 inches. Each arm extended a length of 30 
inches from the perimeter of the center platform, which had a 
•
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diameter of 12 inches. Each subject was randomly assigned an 
initial maze orientation which remained fixed for the duration 
of the experiment. This was to control for any possible 
directional preference with respect to external cues. Prior 
to beginning RAM testing, rats were given 8 days (5 min/day) 
of habituation phase. During this period, the appetetive 
reinforcer (Froot Loops) were liberally scattered on the RAM; 
then they were individually placed onto the center platform 
and allowed to explore the RAM and acclimate to the new 
environment. SUbjects were tested in a random alternating 
time schedule (alternating from a daily testing period of 9­
10: 30 AM 'or 12-1: 30 PM or 2: 30-4: 00 PM). All behavioral 
testing was performed in a blind manner with 3 experimenters 
contributing to the effort daily. After each session, 'the 
maze was thoroughly wiped with a semi-wet towel to nullify any 
odor effects. 
Initially 5 arms were randomly chosen and consistently 
baited every session. At the beginning of the testing period, 
each rat was placed at the center platform and permitted to 
choose among the arms until it either successfully completed 
the test (obtained all rewards) or until 10 minutes had 
elapsed. A white masking tape was taped around each arm 3 
inches in front of the white bait cup, and an entry into an 
•
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arm was defined as two front paws beyond the tape. If no 
choices were made during the first 5 minutes of the session, 
animals were discontinued and taken off the maze. 
Arm choices and time required to complete a session were 
recorded. A working memory correct error (WMCE) was defined 
as an entry into an arm from which the rat had already 
obtained food while reference memory error (RME) was 
determined as an entry into an arm that was never baited. In 
addition, a working memory incorrect error was defined as an 
entry in which the rat had already made a RME. Choice 
accuracy (ChA) was recorded as the number of correct choices 
made before making an error. In case rats did not enter arms, 
consistent entry (CE) of a sUbject was defined as at least 1 
entry per session for at least 3 sessions per block (6 
sessions). As a rough measure of the general activity of the 
rat, choice latency (ChL) was calculated as the session 
latency (SesL) divided by the total number of arms entered 
(Tch). In the fixed RAM design, working memory was comparable 
to short-term memory, because it was a measure of the 
sUbjects' ability to remember which arms were recently entered 
(seconds to at most 10 minutes). Reference memory, in 
contrast, was analogous to long term memory insofar as it was 
a measure of the rat's ability to remember which arms were 
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never baited over an extended period of time. RAM testing 
continued for 24 days (4 blocks). 
Locomotor Behavior 
Locomotor testing commenced 4 days following the 
completion of RAM. Rats were individually placed inside a 
treadmill from which they could not escape and were given 5 
minutes to move freely. The number of revolutions made were 
recorded for the first 90 seconds and for the entire five 
minutes. Testing continued for 4 consecutive days. 
Morris Water Maze 
Upon the completion of locomotor testing, rats were put 
on a free feeding diet regime and given 7 days resting period 
prior to beginning the Morris water Maze (MWM). The Water 
Maze resembled a circular pool which was 200 cm in diameter. 
Luke warm water (-30 C) was filled up to 15 inches high with 
the walls of the pool extending 6 inches above the surface of 
the water. The MWM was arbitrarily divided into 4 equal 
quadrants that were formed by imaginary lines which 
intersected at the center of the pool at right angles. An 
arbitrary direction (N, E, S, W) was given to where the 
imaginary lines met the wall of the maze. During the 
• 
An Animal Model of AD 15 
habituation phase, animals were introduced to the water maze 
by individually'placing them into the water from the North 
then the East, 90 seconds each. Habituation continued in this 
manner for 3 days. On the fourth day, testing began after a 
sufficient amount of powdered milk was added to the water as 
to hide the escape platform (2 cm below the water surface) 
which always resided in the middle of the SW quadrant. For 
eight days, rats were given two consecutive trials per day by 
placing them into the water (head facing the maze wall) from 
the North and East start positions (start positions 
alternating daily). For each trial, sUbjects were left to 
swim freely for 90 seconds or until the platform was found. 
If it was not found within 90 seconds, the rat was guided to 
the platform and allowed to rest there for 10 seconds. For 
each trial, escape latencies were timed and recorded. 
Tissue preparation and Histologies 
Eight to 14 days following the termination of behavioral 
testing, animals were anesthetized with an overdose of sodium 
pentobarbital and transcardially perfused through the 
ascending aorta of the heart with 300ml of PBS followed by 
600ml of 4% paraformaldehyde. The brains were removed and 
post-fixed in 4% paraformaldehyde overnight and cryoprotected 
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in a 20% phosphate-buffered sucrose solution of 4% 
paraformaldehyde' until the investigators were ready to process 
them for histological analysis. All brains were sectioned 
(20um) and stained for the analysis of hippocampal 
cytoarchitecture with cresyl violet, which stains nissel 
bodies that are found in all cell bodies. In addition, every 
other section of each brain was stained with congo red and 
were counterstained with hematoxylin in order to visualize any 
possible amyloid deposits and cell bodies surrounding them. 
In 9 of the brains (2 from PBS group, 2 from BAP+IBO 
group, and 1 each from other groups), GFAP and Alz-50 
immunocytochemistry was also performed in addition to the 
cresyl violet and congo red stains. GFAP was utilized to 
visualize the extent of gliosis in hippocampal lesions and 
Alz-50 for immunolabeling the tau protein, which has been 
associated with neurodegeneration []. The sections (2 Oum) were 
washed with PBS (pH 7.4) and blocked with 10% normal horse 
serum (NHS), and incubated for 36 hours with the mouse anti­
GFAP primary antibody (1:200) or mouse monoclonal Alz-50 
primary antibody (1:5) at 4 C. The sections were then washed 
and treated with a biotinylated anti-mouse secondary antibody 
(raised in a horse) followed by Avidin-Biotin Complex (ABC) 
and reacted with diaminobenzedine (DAB) with 0.001% hydrogen 
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peroxide. A control immunocytochemical procedure was 
conducted by omitting the primary antibody. 
statistical Analysis 
The present study used a between-within sUbject mixed 
design (7 groups X 4 blocks for RAM and 7 groups X 8 days for 
MWM) . Due to the difficulties in performing a repeated 
measures ANOVA, however, the radial arm maze and water maze 
data were tentatively analyzed using the oneway ANOVA. 
Selectively for each block (6 days/block) of the RAM and each 
session of the MWM, Oneway ANOVAs were performed using 
'groups' as the independent variable in order to compare the 
means of 6 independent samples for each of the dependent 
measure (e.g. choice accuracy, escape latency, etc.). A post 
hoc Student-Newman-Keuls (SNK) procedure was used to reveals 
which group(s) were significantly different each other. For 
the locomotor data, a t-test was employed to compare the mean 
number of revolutions between the animals that consistently 
entered arms versus those that did not. 
Results 
Radial Arm Maze 
The general trend showed that only IBO (H) and 
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BAP (L) +IBO (L) groups were impaired in learning and memory 
performance on the RAM. During block 1 of testing, there were 
no significant differences between groups in any of the 
dependent measures, except the BA+IBO group which made 
significantly less arm choices compared to the IBO(L) groups 
(SNK p < 0.05). None of the animals in the BAP+IBO group met 
the criterion for consistently entering the arms in any of the 
blocks; therefore, dependent variables could not be measured 
and statistical analysis was omitted for the BAP+IBO group 
except total number of choices (Tch) which revealed to be 
significantly lower than all other groups in all blocks (p < 
0.001). 'By block 2, group effects showed that choice 
accuracy, total number of choices, working memory incorrect 
errors, and total errors were significantly different 
(F(4,73)=3.951 p < 0.006, F(5,156)=9.023 P < 0.001, 
F(4,73)=3.987 P < 0.006, F(4,73)=2.5987 P < 0.05, 
respectively). Post hoc SNK analyses revealed that the IBO (H) 
group was significantly impaired in choice accuracy and made 
significantly greater number of working memory incorrect 
errors and total errors (SNK P < a• 05) compared to the 
controls. While all other groups were not significantly 
different from the controls in block 3, groups effects were 
found in choice accuracy, working memory correct error, and 
•
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total error (F(S,74)=3.S0S4 p < 0.001, F(S,74)=3.716 P < 
O.OOS, F(S,74)=2'.9693 P <O.OS, respectively), which was mainly 
attributed to significant memory deficits manifested by the 
IBO(H) group in all of the above dependent measures (SNK p < 
O.OS). By block 4, group effects disappeared for all memory 
measures, but SNK post hoc analysis revealed that the IBO(H) 
group committed significantly more working memory incorrect 
errors than the BAP(H) group. statistical analysis 
demonstrated that BAP(L) or BAP(H) groups were not 
significantly different from the SALINE controls in any of the 
dependent measures in any of the blocks of the RAM. 
Locomotor Behavior 
No significant overall differences were found in 'the 
number of revolutions made between the animals that 
consistently entered arms versus those that did not during the 
first 90 seconds or the entire S minutes of locomotor testing 
(F=1.47 p > 0.1, F=1.69 P > O.OS, respectively. In addition, 
there were no significant differences between entering and not 
entering animals during each of the 4 days of locomotor 
testing in the first 90 seconds or S minutes (p > 0.1). 
Morris Water Maze 
• 
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No significant group effects were found until session 3 
. 
of testing (F(S,20)=3.263 p < O.OS), wherein the IBO(L) group 
demonstrated a significantly shorter escape latency than 
BAP(L)+BAP(L) (SNK P < O.OS), but not significantly different 
from any other group. All other escape latencies were not 
significantly different between groups for the remaining 
sessions (p > o. OS) . While the control and IBO (L) groups 
showed consistently shorter escape latencies session 
after session, however, IBO(H) and BAP(2S+3S)+IBO(L) groups 
demonstrated poor learning rates over the session. In fact, 
the BAP(2S-3S)+IBO(H) group showed an extinction of learning 
during the final 2 sessions (7 and 8). While the general 
learning rates of the BAP(2S-3S) (L) and BAP(2S-3S) (H) did not 
appear to be impaired, these animals showed an irregular up 
and down "saw-shaped" learning curves. 
Histologies 
A thorough histological analysis of the hippocampal 
cytoarchitecture has not yet been performed. preliminary 
analysis, however, suggests that there is a profound 
disruption of the hippocampus accompanied by reactive gliosis 
in S of the 6 animals injected with BAP(2S-3S) (L)+IBO(L). 
Adjacent to sites of degeneration, Alz-SO immunoreactivity was 
-An Animal Model of AD 21 
also markedly enhanced in the BAP(2S-3S) (L)+IBO(L) group. In 
all groups, there was a disruption of the cerebral cortex 
immediately dorsal to the injection area due to the burr hole 
made by the drill. In 3 of the S animals injected with a high 
dose of ibotenic acid, profound lesions were evident in the 
hippocampus. In all other animals, there was no obvious 
damage of the hippocampal cytoarchitecture. A more thorough 
analysis must be conducted, however, to confirm intracerebral 
depositions of BAP(2S-3S) with congo red and to quantitate the 
degree of each lesion. 
In the 6 rats that were randomly selected from the groups 
(1 per group) for glial acidic fibrillary protein (GFAP) 
immunocytochemistry, glial cells were counted as a part of 
Esther Kang's project. These results showed that the 
experimental animals stained a greater number of GFAP 
immunopositive cells in the hippocampus than the saline 
control. 
Discussion 
The results of this study indicate that the newly 
solubilized BAP(2S-3S) is not directly neurotoxic to 
hippocampal neurons in vivo. As others have suggested 
-An Animal Model of AD 22 
[10,14], however, BAP(25-35) may be involved in promoting the 
. 
vulnerability of otherwise healthy neurons to excitotoxic 
damage (e. g . ibotenic acid) presumably by disrupting the 
cells' ability to maintain calcium homeostasis. This is not 
surprising given that excitatory amino acids (e.g. glutamate) 
and their analogs (e.g. ibotenic acid) exert their toxicity by 
creating a rapid and sustained elevation in intracellular 
calcium, thereby interacting with BAP(25-35) at a cellular 
level [2]. While a low (4nmol/ul) or high dose (8nmol/ul) of 
BAP(25-35) or a low dose (lug/ul) of ibotenic acid (IBO) 
injected separately had no appreciable effect on 
learning/memory nor produced significant lesions, co­
injections of low doses of BAP(25-35)+IBO resulted in profound 
deficits in learning performance accompanied by severe 
necrosis of the hippocampus and reactive gliosis. 
Not surprisingly, bilateral intrahippocampal injections 
of a high dose of IBO resulted in significant deficits in 
choice accuracy and working memory on the radial arm maze 
associated with marked disruption of hippocampal 
cytoarchitecture. These results are consistent with previous 
reports, suggesting that lesions of the hippocampus 
selectively impair working memory [4]. It is difficult to 
determine why none of the animals in the BAP(25-35)+IBO group 
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did not consistently enter arms in the RAM task, because their 
motor activity during a treadmill test was not significantly 
different from the controls, and no differences were found 
between the rats that ran the RAM and those that did not. 
However, it is noteworthy to mention that animals in the 
BAP(25-35)+IBO group showed a diminished ability to acclimate 
to the stress-provoking radial arm maze environment; this was 
evident by freezing, urinating, and/or defacating on the 
center platform throughout the testing procedure. It is also 
possible that lesions due to co-injections of BAP(25-35)+IBO 
are not completely selective to the injection ares and may 
indiscriminantly affect area associated with habituation 
and/or decision making. 
While injections of BAP(2S-35) (L) or BAP(25-3S) (H) were 
not directly neurotoxic and did not impair performance on the 
RAM task, a "saw-shaped" learning curve was observed in the 
water maze task. While these rats did learn the maze, 
however, their learning was irregular and sporadic--markedly 
improving in 1 session and forgetting in the next. This 
phenomenon may be related to BAP(25-35)'s ability to disrupt 
cellular calcium homeostasis since a fine regUlation of 
intracellular calcium is crucial for hippocampal long-term 
potentiation (LTP) , an electrophysiological phenomenon 
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intimately associated with learning/memory. 
Collectiveiy, the results of the present study suggest 
that BAP(25-35) does exert action on neurons in the 
hippocampus, however, is not directly neurotoxic in vivo. 
Evidenc~ suggests that BAP(25-35) destabilizes intracellular 
regulation of calcium in the hippocampus, which may affect 
learning/memory as seen by the "saw-shaped" learning curve in 
the water maze, and may cause neurons to become highly 
vulnerable to other neuronal insults (e.g. glutamate, a 
ubiquitous neurotransmitter) . This may resemble a 
pathological scenario in the brains of Alzheimer's patients, 
such that neurons that are adjacent to neuritic plaques with 
heavy glutaminergic inputs may be at high risk for 
degeneration. 
The implications of this research are far-reaching; 
however, a replication is necessary to confirm the verity of 
these results. In addition, the full length peptide, BAP(l­
40), should be investigated for its effects on learning/memory 
in a similar context to the present study. Since in vitro 
evidence suggests that BAP(25-35) works via a calcium-mediated 
mechanism, future studies should test this hypothesis by the 
use of calcium channel blockers (e.g. nimodipine, dantrolene, 
etc.) or calcium chelators (e.g. EGTA) in vivo to protect 
An Animal Model of AD 25 
neurons from the effects of BAP(25-35) and/or ibotenic acid . 
. 
Investigation in this direction may lead to a possible 
treatment for Alzheimer's disease. 
•
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Figure caption 
Figure 1. Group differences in mean percent animals 
consistently entering arms over the sessions. consistent 
entry was characterized as at least 1 entry per session for at 
least 3 sessions in 1 block (1 block=6 sessions). 
Figure 2. Group differences in the mean number of arms entered 
over the blocks (1 block=6 sessions). Vertical lines indicate 
S.E.M. *p<O.05, **p<O.OOl significantly different from the 
saline controls. 
Figure 3. Group differences in the mean number of working 
memory incorrect errors (WMIE) committed over the blocks (1 
block=6 sessions). A WMIE is an arm entry into an arm that 
the rat has already made a reference memory error in the same 
session. vertical lines indicate S.E.M. *p<O.05 significantly 
different from the saline controls. 
Figure 4. Group differences in the mean number of working 
memory correct errors (WMCE) committed over the blocks (1 
block=6 sessions). A WMCE is an arm entery into an arm that 
the rat has already obtained food in the same session. 
..
 
An Animal Model of AD 30 
vertical lines indicate S.E.M. *p<0.05 significantly 
different from the saline controls. 
Figure 5. Group differences in mean choice accuracy (ChA) over 
the blocks (1 block=6sessions). ChA is defined as the number 
of correct arm entries prior to making an error. vertical 
lines indicate S.E.M. *p<0.05 significantly different from 
the saline controls. 
Figure 6. Differences in mean number of revolutions made in 
the treadmill motor activity test in 5 minutes between the 
rats that ran the RAM and those that did not. Vertical lines 
indicate S.E.M. There is no significant difference at p=0.05 
level. 
Figure 7. Group differences in mean escape latencies (seconds) 
over days (2 trials/day). *p<0.05 significantly different 
from the saline controls. 
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